By Maureen Newman The recent announcement of positive results for the AMBITION trial testing combinatorial ambrisentan and tadalafil in patients with pulmonary arterial hypertension (PAH) is bringing more attention to the need to actively recruit participants for clinical trials. Without patients and clinicians interested in...
By Patricia Inacio, PhD In a new study entitled “Symptom Interference Severity and Health-Related Quality of Life in Pulmonary Arterial Hypertension,” researchers determined which symptoms experienced by those with pulmonary arterial hypertension are the most self-limiting and interfering with patients daily quality of...
By Christine Traxler, MD An 18 year-long prospective study on the length of television watching and the risk of pulmonary embolism revealed a positive correlation between the length of time a person watches television per day and the risk...
By Christine Traxler, MD It was once thought among doctors that patients with pulmonary hypertension, many of whom can’t even walk a short distance without being short of breath, shouldn’t exercise. Pulmonary hypertension is a disease that leads to high blood pressure...
